ALEX RAFANAN: Open Payments
NPI 1679518500 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 19 payments from 11 companies in 2025. Trend: 2023 $394 · 2024 $344 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $157 |
| Amgen Inc. | 1 | $114 |
| Medtronic, Inc. | 1 | $94 |
| Lilly USA, LLC | 5 | $89 |
| Dexcom, Inc. | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $38 |
| Radius Health, Inc. | 1 | $25 |
| BETA BIONICS, INC. | 1 | $22 |
| Stryker Corporation | 1 | $19 |
Products named: DUPIXENT, UPLIZNA, CLOSUREFAST, MOUNJARO, Dexcom G6 Transmitter, GVOKE HYPOPEN, Ozempic, iLet Bionic Pancreas.
Industry payments across FL — which companies pay providers there.
